Cargando…
The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome
Recently, we have shown that HLA-A*02:01 and HLA-A*24:02 in de novo metastatic prostate cancer (MPCa) have an important role in disease progression. Since de novo MPCa represents a small group among patients diagnosed with prostate cancer (PCa), it was obvious to try to extend the validity of our re...
Autores principales: | Stokidis, Savvas, Baxevanis, Constantin N., Fortis, Sotirios P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572221/ https://www.ncbi.nlm.nih.gov/pubmed/37833904 http://dx.doi.org/10.3390/ijms241914454 |
Ejemplares similares
-
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer
por: Stokidis, Savvas, et al.
Publicado: (2020) -
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2023) -
Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
por: Goulielmaki, Maria, et al.
Publicado: (2023) -
Radiotherapy-Related Gene Signature in Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2022) -
Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
por: Kogionou, Paraskevi, et al.
Publicado: (2023)